Drug Shortage Report for VISKAZIDE

Last updated on 2022-04-27 History
Report ID 151232
Drug Identification Number 00568627
Brand name VISKAZIDE
Common or Proper name HYDROCHLOROTHIAZIDE PINDOLOL
Company Name XEDITON PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE PINDOLOL
Strength(s) 25MG 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Pack of 3 x 35 Tablets
ATC code C07CA
ATC description BETA BLOCKING AGENTS AND OTHER DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-12-20
Actual start date
Estimated end date 2022-01-31
Actual end date 2022-04-13
Shortage status Resolved
Updated date 2022-04-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2020 WINSTON PARK DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6X7
Company contact information george.gafrey@xediton.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-04-27 French Compare
v4 2022-04-27 English Compare
v3 2021-12-21 English Compare
v2 2021-12-15 French Compare
v1 2021-12-15 English Compare

Showing 1 to 5 of 5